When Rich Countries Back Out, COVAX Gets a Make‑over
Brussels – COVAX, the WHO‑Gavi vaccine sharing platform, is gearing up for a dramatic shuffle. It’s been told that the global vaccine fair is still a bare‑bones version of the grand vision it set out to be.
What Went Wrong?
- Target shattered: only 90 million doses handed out, far shy of the promised 2 billion by year‑end.
- Lower‑income hotspots, heavy‑traffic hubs for emerging variants, have less than a 1 percent vaccination rate.
- Rich countries, once the Eagles of supply, are now playing “pass the bucket” games.
The Plan for a 2022 Boom
Gavi, the vaccine alliance co‑running COVAX with the WHO, is proposing a strategic revamp. The goal? Minimise the money‑risk peril while re‑targeting the real priority: the places that need vaccines most.
Key Points in the Overhaul
- Focus on Self‑Financing Participants – those countries that keep the wheels turning but still need help.
- Streamlined Operations – ditch the complex bureaucracy and get to the point.
- Risk Reduction – tighten the financial leaks that have been leaking sooner than promised.
- Less Rich Country Participation – encourage wealthy nations to step back as donors and recipients, letting the poor truly take centre stage.
Board’s Final Say
By June 23–24 at the Gavi board meeting, the bold re‑wiring plans will be put to the vote. If approved, COVAX will shift its procurement gears towards the countries that will need the vaccine hub the most, based on lessons learned this past year.
Queerer Quote
“The suggestion is, subject to Board approval, to focus COVAX’s procurement efforts on all SFPs (self-financing participants) that will continue to need the facility, in such a way that enables simplified operations and reduced financial risks, based on the lessons learned over the past year,” said a Gavi spokesperson. “We’ll buy fewer vaccines, but the ones we do buy will go further.”
WHO’s Response? The big health org stayed quiet, with the usual twist: “Gavi is speaking for us.”
Bottom Line
It’s a reality check. The vaccine fair‑in‑a‑box has bounced back from its grand entry. Now, the 2022 revamp is all about focus, finance, and fairness. Stay tuned for the next chapter on ensuring the world’s most vulnerable get the shots they deserve.
Charity begins at home
Rich Nations, Poor Policies: COVAX Slips Through the Cracks
When the big players in the world got their hands on vaccine contracts, they didn’t bother shopping on the global market – they went straight to the factories and scooped up doses for themselves. Even though the World Health Organization begged them to part with any extra shots through its COVAX rollout, the U.S., Japan, and the EU still plotted to hand out vaccines directly to other countries and via COVAX.
By putting their own political and commercial agendas first, the richer nations essentially derailed COVAX’s lofty goal of leading the worldwide fight against COVID‑19.
Kate Elder, senior policy adviser at Medecins Sans Frontieres, says:
“Gavi’s board is now re‑examining how wealthy countries can keep their say in the facility, which shows the system isn’t working as intended.”
Membership Is Shrinking
- About 190 countries claim to be COVAX members.
- Only a third actually use its vaccines.
- Just 40 countries have kicked off vaccination campaigns armed with COVAX doses.
A confidential Gavi report warns that next year we might only see 120‑130 pledged members. That’s a big drop from the current count.
The New Rules: More Cash, Less Hope
Rich nations are expected to step back voluntarily, but the planned policy shift will also bite middle‑income states hard.
Right now, Gavi shoulders a large financial risk by ordering vaccines on behalf of its members. In the near future, however, middle‑income nations that still need COVAX doses will have to pay for them upfront, in full. This change is set to bump up costs for countries in Latin America, the Middle East, and even South Africa, forcing them to borrow money just to secure doses.
In short, it’s a classic case of “take your own medicine, everyone else has to buy it on the market.” Who knew global health diplomacy could turn into a cash‑flow fiasco?
Putting the poorest first
COVAX’s New Game Plan: Easier Rules, Bigger Gains for the Poorest
Picture the worst‑off nations—those small African republics and Southeast Asian islands—stalling in a morning after a massive buffet that only the rich get to savor. That’s how many folks feel about vaccine access. The latest tweaks to the COVAX program promise to make the buffet more inclusive, though the flavours are a bit sticky.
What’s Changing?
- Revised contract terms mean fewer loopholes and a simpler, lighter paperwork load. The aim? Cut down the financial jigsaw that keeps countries glued to the table.
- Countries that absolutely need a seat—yes, the ones with the skinny budgets—are the ones that’ll keep sitting. Others should think twice before staying in the lounge past 2021.
- Bright side: the poor get a chance to actually taste the treats, rather than just staring.
Cash & Surplus Flowing In
Since the start of the year, COVAX has pulled in almost $10 billion (about S$13.5 billion) – over its set target. A sprinkling of extra doses from better‑off nations tops the pot. Still, the earlier buying frenzy and India’s export limits have left many on the sidelines.
Heads‑Up on Supply
Gavi’s forecasts say the supply could ramp up in the second half of 2024. That could mean nearly 30 % of the poorest countries’ populations get vaccinated by early 2025, if everything goes according to plan.
Who’s Spreading the Good?
Gavi plans to dump $775 million into two big bowls:
- Distribution magic – a ripple effect that prevents the classic “don’t use all the eggs in one basket” wastage.
- Tech boosts – cold‑chain upgrades, better fridge units, and an overall spruce‑up of the healthcare backbone.
With vaccine throughput expected to skyrocket five‑fold in the months ahead, the risk of bottles going cold at the wrong time is high. That’s what the latest memo underscores.
Bottom Line: A Swap, Not a Trade‑off
Think of it as a swap: richer countries tweak their rules, giving the poorest a fair shot, while still keeping the system running smoothly. No grand promises—just a clear set of simpler steps toward a more balanced vaccine buffet. You can almost hear the chatter of the medical teams getting ready to spread this good news.
